Application of TZERO calibrated modulated temperature differential scanning calorimetry to characterize model protein formulations

被引:10
作者
Badkar, A
Yohannes, P
Banga, A
机构
[1] Mercer Univ, So Sch Pharm, Atlanta, GA 30341 USA
[2] Gwinnett Univ Ctr, Georgia Perimeter Coll, Lawrenceville, GA 30043 USA
关键词
T-ZERO modulated DSC; circular dichroism; thermal stability; thermal analysis; lysozyme; protein unfolding;
D O I
10.1016/j.ijpharm.2005.11.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to evaluate the feasibility of using T-ZERO modulated temperature differential scanning calorimetry (MDSC) as a novel technique to characterize protein solutions using lysozyme as a model protein and IgG as a model monoclonal antibody. MDSC involves the application of modulated heating program, along with the standard heating program that enables the separation of overlapping thermal transitions. Although characterization of unfolding transitions for protein solutions requires the application of high sensitive DSC, separation of overlapping transitions like aggregation and other exothermic events may be possible only by use of MDSC. A newer TZERO calibrated MDSC model from TA instruments that has improved sensitivity than previous models was used. MDSC analysis showed total, reversing and nonreversing heat flow signals. Total heat flow signals showed a combination of melting endotherms and overlapping exothermic events. Under the operating conditions used, the melting endotherms were seen in reversing heat flow signal while the exothermic events were seen in nonreversing heat flow signal. This enabled the separation of overlapping thermal transitions, improved data analysis and decreased baseline noise. MDSC was used here for characterization of lysozyme solutions, but its feasibility for characterizing therapeutic protein solutions needs further assessment. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:146 / 156
页数:11
相关论文
共 19 条
[1]   A central composite design to investigate the thermal stabilization of lysozyme [J].
Branchu, S ;
Forbes, RT ;
York, P ;
Nyqvist, H .
PHARMACEUTICAL RESEARCH, 1999, 16 (05) :702-708
[2]   STRATEGIES TO SUPPRESS AGGREGATION OF RECOMBINANT KERATINOCYTE GROWTH-FACTOR DURING LIQUID FORMULATION DEVELOPMENT [J].
CHEN, BL ;
ARAKAWA, T ;
HSU, E ;
NARHI, LO ;
TRESSEL, TJ ;
CHIEN, SL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (12) :1657-1661
[3]   Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation [J].
Chi, EY ;
Krishnan, S ;
Randolph, TW ;
Carpenter, JF .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1325-1336
[4]   Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor [J].
Chi, EY ;
Krishnan, S ;
Kendrick, BS ;
Chang, BS ;
Carpenter, JF ;
Randolph, TW .
PROTEIN SCIENCE, 2003, 12 (05) :903-913
[5]   Modulated temperature differential scanning calorimetry: A novel approach to pharmaceutical thermal analysis [J].
Coleman, NJ ;
Craig, DQM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 135 (1-2) :13-29
[6]   Maltodextrins as lyoprotectants in the lyophilization of a model protein, LDH [J].
Corveleyn, S ;
Remon, JP .
PHARMACEUTICAL RESEARCH, 1996, 13 (01) :146-150
[7]   The use of modulated temperature DSC for the study of pharmaceutical systems: Potential uses and limitations [J].
Craig, DQM ;
Royall, PG .
PHARMACEUTICAL RESEARCH, 1998, 15 (08) :1152-1153
[8]   New approach to stability assessment of protein solution formulations by differential scanning calorimetry [J].
Cueto, M ;
Dorta, MJ ;
Munguía, O ;
Llabrés, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 252 (1-2) :159-166
[9]   Destabilization of human serum albumin by polyethylene glycols studied by thermodynamical equilibrium and kinetic approaches [J].
Farruggia, B ;
Garcia, G ;
DAngelo, C ;
Pico, G .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1997, 20 (01) :43-51
[10]   Protective mechanism of stabilizing excipients against dehydration in the freeze-drying of proteins [J].
Liao, YH ;
Brown, MB ;
Quader, A ;
Martin, GP .
PHARMACEUTICAL RESEARCH, 2002, 19 (12) :1854-1861